Results 341 to 350 of about 576,280 (398)
Some of the next articles are maybe not open access.

Atopic dermatitis

Nature Reviews Disease Primers, 2018
Stephan Weidinger   +2 more
exaly   +4 more sources

Atopic dermatitis: an expanding therapeutic pipeline for a complex disease

open access: yesNature Reviews Drug Discovery, 2021
Atopic dermatitis (AD) is a common chronic inflammatory skin disease with a complex pathophysiology that underlies a wide spectrum of clinical phenotypes. AD remains challenging to treat owing to the limited response to available therapies.
Thomas Bieber
exaly   +2 more sources

North American Contact Dermatitis Group Patch Test Results: 2019–2020

Dermatitis, 2023
: Background: Patch testing is an important diagnostic tool for assessment of allergic contact dermatitis (ACD). Objective: This study documents the North American Contact Dermatitis Group (NACDG) patch testing results from January 1, 2019, to ...
J. DeKoven   +17 more
semanticscholar   +1 more source

Dermatitis

Emergency Medicine Clinics of North America, 1985
Dermatitis, the inflammatory response of the skin to various factors, may present in a variety of forms. Atopic dermatitis, contact dermatitis, nummular eczema, seborrhea, and stasis dermatitis, conditions with which the patient may present to the emergency department, either in the acute stage or with exacerbation of a chronic condition, are reviewed ...
G, Sternbach, J P, Callen
openaire   +2 more sources

North American Contact Dermatitis Group Patch Test Results: 2017–2018

Dermatitis, 2021
Background Patch testing is an important diagnostic tool for assessment of allergic contact dermatitis (ACD). Objective This study documented the North American Contact Dermatitis Group (NACDG) patch testing results from March 1, 2017, to December 31 ...
J. DeKoven   +13 more
semanticscholar   +1 more source

Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials

British Journal of Dermatology, 2020
Baricitinib, an oral selective Janus kinase 1 and 2 inhibitor, effectively reduced atopic dermatitis (AD) severity in a phase II study with concomitant topical corticosteroids.
E. Simpson   +23 more
semanticscholar   +1 more source

Ethylenediamine dermatitis*

Contact Dermatitis, 1986
32 ethylenediamine‐sensitive patients were studied to determine cross‐sensitivity reactions. Reaction to other aliphatic polyamines proved to be very high, whereas no significant result was obtained to antihistamines, cither topically or orally.
BALATO, NICOLA   +3 more
openaire   +3 more sources

The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis

Nature Immunology, 2018
Teruki Dainichi   +2 more
exaly   +2 more sources

Home - About - Disclaimer - Privacy